Civil Rights
Movements, leaders, victories and the continuing fight for equality.
Explore the people, places, events, achievements, struggles and stories that shaped our journey.
Movements, leaders, victories and the continuing fight for equality.
Innovation, patents, science, technology and world-changing contributions.
Pioneers, champions, Negro Leagues, records, activism and excellence.
Meet the people whose lives, choices and achievements shaped the journey.
Black towns, communities, institutions and places where history happened.
Moments that changed communities, movements, institutions and the nation.
In 1968 Shirley Chisholm became the first Black woman elected to the United States Congress. In 1972 she launched a campaign for the Democratic presidential nomination, breaking another political barrier.
MORE →Reflects the personal views, recollections, and perspective of the author, Mike Davis.
This is a personal recollection on the Move fire on May 13, 1985
PPD Headquarters in Wilmington, North Carolina | |
| Type | Subsidiary |
|---|---|
| Industry | Contract research organizations Pharmaceutical Biotechnology |
| Founded | 1985 |
| Headquarters | Waltham, Massachusetts, United States |
| Key people | See Senior Leadership Team page of the PPD Website[1] |
| Products | Contract clinical research for pharmaceutical, biotechnology, medical device, academic and government organizations; services include drug development, laboratory and lifecycle management. |
| Revenue | |
Number of employees | 40,000+ (2023) |
| Parent | Thermo Fisher Scientific |
| Website | https://www.ppd.com |
Pharmaceutical Product Development (PPD) is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services. In December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific.
PPD was founded by Fred Eshelman, Pharm.D., as a one-person consulting firm in 1985. The following year, he expanded the company's scope to include development services and relocated operations from Maryland to North Carolina.
In January 1989, the company incorporated in North Carolina.
In January 1996, PPD issued its initial public stock offering and began trading on the Nasdaq National Market System under the symbol PPDI.
In October 2005, PPD's board of directors adopted an annual cash dividend policy.
In July 2009, the company promoted Eshelman to executive chairman and names David Grange chief executive officer.[3] In January 2010, the company commemorated the 25th anniversary of its founding. In June the same year, PPD spun off its compound partnering division as a new and independent publicly traded company, Furiex Pharmaceuticals.[4]
A year later, in May 2011, David Grange retired as chief executive officer of PPD.[5] In September, PPD's board of directors named Raymond Hill as PPD's new chief executive officer.[6] In December of that year, the company was acquired by affiliates of The Carlyle Group and affiliates of Hellman & Friedman in an all-cash transaction valued at approximately $3.9 billion.[7]
In May 2012, PPD's board of directors named David Simmons as chairman and CEO.[8]
In August 2013, PPD acquired Acurian.[9]
In December 2014, PPD announced an agreement with SNBL to form a joint venture to provide full range of clinical development services in Japan.[10]
In May 2015, PPD expanded its network of U.S.-based research sites via strategic relationship with Radiant.
In June 2016, PPD expanded its network of global research sites via strategic relationship with Synexus. In September of that year, PPD acquired Evidera.[11]
In April 2017, Hellman & Friedman and affiliates of The Carlyle Group entered into definitive agreements to recapitalize PPD and expand the company's ownership to include two new investors, a subsidiary of the Abu Dhabi Investment Authority and an affiliate of GIC Private Limited, Singapore's sovereign wealth fund.[12]
In July 2018, PPD launched a new site solution.[13] In the same month, Synexus announced U.S.-based registry to power major longitudinal study on brain aging.[14]
In February 2019, PPD made a deal with China's HLT to create data science-driven research solutions.[15] In May of the same year, PPD's Evidera acquired RWE provider Medimix.[16] In September 2019, PPD's Accelerated Enrollment Solutions acquired global site business from Bioclinica.[17]
In February 2020, PPD issued its initial public stock offering and began trading on the Nasdaq Global Select Market under the symbol PPD.[18]
In April 2021, Thermo Fisher Scientific announced plans to acquire PPD for $17.4 billion.[19] The acquisition was complete in December 2021.[20][21]
Source: Wikipedia. Article content is retrieved live through the MediaWiki API.
Pharmaceutical Product Development (PPD) is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services. In December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific.
Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion.
PPD may refer to:
Syneos Health (formerly InVentiv Health Incorporated and INC Research) is an American company that provides contract research and commercial services to pharmaceutical and biotechnology companies. Based in Morrisville, North Carolina, the company specializes in helping other companies with late-stage clinical trials, but also provides commercial services to market health treatments. Syneos Health was formed from the merger of InVentiv Health and INC Research, each formed from the consolidation of several companies in the contract research industry. It was listed on Nasdaq until 2023 when the company was taken private by Elliott Investment Management.
Before the 1921 destruction of Tulsa’s Greenwood District, Black residents had created a remarkable center of business and community life. The district included stores, professional offices, entertainment venues and homes owned by Black citizens. Understanding Greenwood means learning what was built—not only what was burned.
MORE →Brown v. Board of Education in 1954.